إعلان
إعلان

ABEO

ABEO logo

Abeona Therapeutics Inc. Common Stock

5.16
USD
برعاية
-0.06
-1.21%
٠٦ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

5.21

+0.05
+1.03%

تقارير أرباح ABEO

النسبة الإيجابية المفاجئة

ABEO تفوق 22 من 40 آخر التقديرات.

55%

التقرير التالي

بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$6.36M
/
-$0.32
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+220.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
+128.57%

Abeona Therapeutics Inc. Common Stock earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, ABEO reported earnings of -0.10 USD per share (EPS) for Q3 25, beating the estimate of -0.29 USD, resulting in a 66.19% surprise. Revenue reached --, compared to an expected 5.64 مليون, with a -100.00% difference. The market reacted with a +18.47% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.32 USD, with revenue projected to reach 6.36 مليون USD, implying an زيادة of 220.00% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
For Q3 2025, Abeona Therapeutics Inc. Common Stock reported EPS of -$0.10, beating estimates by 66.19%, and revenue of $0.00, -100% below expectations.
The stock price moved up 18.47%, changed from $4.17 before the earnings release to $4.94 the day after.
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
Based on 9 المحللين, Abeona Therapeutics Inc. Common Stock is expected to report EPS of -$0.32 and revenue of $6.36M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان